Effects of short-term add-on ezetimibe to statin treatment on expression of adipokines and inflammatory markers in diabetic and dyslipidemic patients.

about

Effects of short-term add-on ezetimibe to statin treatment on expression of adipokines and inflammatory markers in diabetic and dyslipidemic patients.

Item

http://www.wikidata.org/entity/Q48302242

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Effects of short-term add-on e ...... tic and dyslipidemic patients.

@en

Effects of short-term add-on e ...... tic and dyslipidemic patients.

@nl

type

Item

label

Effects of short-term add-on e ...... tic and dyslipidemic patients.

@en

Effects of short-term add-on e ...... tic and dyslipidemic patients.

@nl

prefLabel

Effects of short-term add-on e ...... tic and dyslipidemic patients.

@en

Effects of short-term add-on e ...... tic and dyslipidemic patients.

@nl

P1476

Effects of short-term add-on e ...... etic and dyslipidemic patients

@en

P2093

Cristina Moreno Fajardo

http://www.w3.org/2001/XMLSchema#string

Egidio Lima Dorea

http://www.w3.org/2001/XMLSchema#string

Elizandra Silva Guimarães

http://www.w3.org/2001/XMLSchema#string

Gelba Almeida Pinto

http://www.w3.org/2001/XMLSchema#string

Marcia Martins Silveira Bernik

http://www.w3.org/2001/XMLSchema#string

Maria Cecilia Gusukuma

http://www.w3.org/2001/XMLSchema#string

Mario Hiroyuki Hirata

http://www.w3.org/2001/XMLSchema#string

P2860

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

A review about biomarkers for the investigation of vascular function and impairment in diabetes mellitus

Treatment of Dyslipidemias to Prevent Cardiovascular Disease in Patients with Type 2 Diabetes.

Ezetimibe/simvastatin vs simvastatin in coronary heart disease patients with or without diabetes.

Efficacy, safety and tolerability of ongoing statin plus ezetimibe versus doubling the ongoing statin dose in hypercholesterolemic Taiwanese patients: an open-label, randomized clinical trial

Combination therapy analysis of ezetimibe and statins in Chinese patients with acute coronary syndrome and type 2 diabetes.

Resistin: functional roles and therapeutic considerations for cardiovascular disease.

Influence of metabolic syndrome factors and insulin resistance on the efficacy of ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome and atherosclerotic coronary heart disease risk.

Peripheral mononuclear cell resistin mRNA expression is increased in type 2 diabetic women.

Synergistic anti-inflammatory effect: simvastatin and pioglitazone reduce inflammatory markers of plasma and epicardial adipose tissue of coronary patients with metabolic syndrome.

P31

scholarly article

P356

10.1111/1755-5922.12307

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Alvaro Cerda

Rosario Dominguez Crespo Hirata

P577

2017-10-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28940978

http://www.w3.org/2001/XMLSchema#string